13F filer · CIK 1844002
Alerce Investment Management, L.P.
Chicago, IL · filing since Q4 2020 · last filing Feb 14, 2025
Reported value
$56.8M
$-5.5M vs prior
Positions
5
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $5.5M
Top-10 weight
100.0%
Biggest buys vs Q3 2024
No new or increased positions this quarter.
Biggest sells vs Q3 2024
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | VERONA PHARMA PLC | -117,880 | -57.3% | $-5.5M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q4 2024
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ANNEXON INCCOM | 7,406,024 | $38.0M | 66.89% |
| 2 | AKEBIA THERAPEUTICS INCCOM | 5,747,906 | $10.9M | 19.23% |
| 3 | VERONA PHARMA PLCSPONSORED ADS | 88,000 | $4.1M | 7.19% |
| 4 | AMERICAN WELL CORPCOM CL A NEW | 523,785 | $3.8M | 6.69% |
| 5 | AADI BIOSCIENCE INCCOM | 659 | $2.1K | 0.00% |